| 【Sector Research】China Express Delivery Sector – On-track ASP improvement in Sep; Expect further increase on the back of policy support |
| 【Company Research】COLI (688 HK) – 3Q21 results slightly beat; potential re-rating on anti-cycle land acquisitions |
| 【Company Research】Anta Sports (2020 HK) – Reset expectations and long-term target remains intact |
| 【行業研究】中國房地產 – 房地產政策這次會更加連貫和堅決 |
| CMBI - Recommendation Changes_20211013 |
| 【Sector Research】China AI surveillance – Gov’t projects picking up, power cuts impact limited |
| 【公司研究】龍源電力 (916 HK) – 強勁趨勢將繼續驅動四季度價值重估 |
| 【Fixed Income Research】MOLAND – Quick takes on consent solicitation |
| 【Company Research】Jiangsu Hengli (601100 CH) – Short-term impact of power outage; Wait for more positive signals |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – Proxalutamide expects to deliver differentiated clinical results compared with molnupiravir |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
